# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-19T13:49:14.252353
**Route:** Direct Google API + PDF
**Tokens:** 25157 in / 2448 out
**Response SHA256:** 8fbb9247452c879c

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: Pre-Unwinding Period (January 2018 – March 2023)"
**Page:** 11
- **Formatting:** Clean, no vertical lines. Proper alignment. However, the units in the headers ($M, K) are slightly unconventional for top journals; usually, these are spelled out in the notes or header as "Millions of USD."
- **Clarity:** High. Provides a clear baseline for the two primary groups (BH and HCBS).
- **Storytelling:** Essential. Establishes that HCBS is a larger market, justifying why a simple DiD wouldn't work and why DDD (controlling for group-specific trends) is necessary.
- **Labeling:** Good. Significance stars are not applicable here. $N$ is clearly defined.
- **Recommendation:** **KEEP AS-IS**

### Table 2: "Summary Statistics: Post-Unwinding Period (April 2023 – October 2024)"
**Page:** 11
- **Formatting:** Consistent with Table 1.
- **Clarity:** Good.
- **Storytelling:** Redundant. In top journals, pre and post summary statistics are almost always merged into a single table with "Pre-Period" and "Post-Period" panels (Panel A and Panel B).
- **Labeling:** Clear.
- **Recommendation:** **REVISE**
  - Consolidate Table 1 and Table 2 into a single "Table 1: Summary Statistics." Use Panel A for Pre-Unwinding and Panel B for Post-Unwinding. This saves space and allows for easier ocular comparison of means across the policy break.

### Figure 1: "Monthly Medicaid Spending: Behavioral Health vs. HCBS Providers"
**Page:** 12
- **Formatting:** Professional. Use of a dashed line for the policy intervention is standard. 
- **Clarity:** The "Unwinding begins" text is slightly crowded near the data points. The seasonally adjusted nature of the data is a plus for clarity.
- **Storytelling:** Excellent. It shows the "Parallel Trends" visually before the formal estimation. It clearly illustrates the "Null" result—neither line breaks trend significantly relative to the other.
- **Labeling:** Good. Source note is present.
- **Recommendation:** **REVISE**
  - Move the "Unwinding begins" text to the top of the plot or use an arrow to ensure it doesn't overlap the HCBS line.
  - Change "Total Paid ($ Billions)" to "Seasonally Adjusted Monthly Spending ($ Billions)" to be more precise.

### Table 3: "Triple-Difference Estimates: Effect of Medicaid Unwinding on Provider Outcomes"
**Page:** 17
- **Formatting:** Journal-ready. Proper use of parentheses for SEs and stars for significance.
- **Clarity:** Very high. Each column is a distinct, logical outcome.
- **Storytelling:** This is the "money table" of the paper. It shows the pervasive null across all dimensions of the market.
- **Labeling:** $R^2$ and $N$ are present. Notes define the clustering level.
- **Recommendation:** **KEEP AS-IS**

### Figure 2: "Event Study: DDD Coefficients Relative to Unwinding Start"
**Page:** 19
- **Formatting:** The shaded 95% CI is professional, but the y-axis range (-5 to 5) is much larger than the data variation, making the pre-trend coefficients look "flatter" than they might be.
- **Clarity:** The drift at $k=18$ is visible but clearly noisy. 
- **Storytelling:** Vital for identifying the "parallel trends-in-trends" assumption.
- **Labeling:** Clear.
- **Recommendation:** **REVISE**
  - Tighten the y-axis. The point estimates are between -2 and 1; a y-axis from -3 to 2 would allow the reader to see the pre-trend precision more clearly.
  - Add a note in the caption explicitly mentioning that the widening CI at $k>12$ is due to the staggered rollout (fewer states contribute to late-period estimates).

### Figure 3: "Active Provider Counts: Behavioral Health vs. HCBS"
**Page:** 20
- **Formatting:** Consistent with Figure 1.
- **Clarity:** Good.
- **Storytelling:** Supports the extensive margin argument. However, in AER/QJE, this is often relegated to a panel in a larger "Raw Trends" figure.
- **Labeling:** Good.
- **Recommendation:** **MOVE TO APPENDIX**
  - Figure 1 already shows spending. Figure 3 is secondary evidence. Keep the main text lean.

### Figure 4: "Monthly Provider Exit Rates: Behavioral Health vs. HCBS"
**Page:** 21
- **Formatting:** High-frequency volatility makes this "spiky." 
- **Clarity:** Harder to parse than other figures due to the noise in monthly exit rates.
- **Storytelling:** Important to prove no "hidden" collapse, but the visual is messy.
- **Labeling:** Clear.
- **Recommendation:** **MOVE TO APPENDIX**

### Figure 5: "Medicaid Disenrollment Rates by State"
**Page:** 22
- **Formatting:** Very clean. Use of cohort coloring is excellent.
- **Clarity:** Excellent. Shows the identifying variation for the dose-response.
- **Storytelling:** Crucial for a policy paper to show the "dosage" of the treatment.
- **Labeling:** State abbreviations are clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 6: "Dose-Response: Spending Change vs. Disenrollment"
**Page:** 23
- **Formatting:** The bin-scatter/scatter approach with a fit line is standard.
- **Clarity:** Good. The overlay of BH and HCBS helps visualize the *difference* being null.
- **Storytelling:** Directly visualizes the result in Table 4.
- **Labeling:** Y-axis "Spending Change (%)" is clear.
- **Recommendation:** **KEEP AS-IS**

### Table 4: "Dose-Response: Unwinding Intensity and Differential BH Effects"
**Page:** 24
- **Formatting:** Standard.
- **Clarity:** The "BH Only" column is a good robustness check but makes the table slightly lopsided.
- **Storytelling:** Confirms the visual in Figure 6.
- **Labeling:** Notes are a bit sparse compared to Table 3.
- **Recommendation:** **REVISE**
  - Add more detailed notes explaining the "BH Only" specification (i.e., that it drops the within-state control group).

### Figure 7: "Market Concentration (HHI) by Category"
**Page:** 25
- **Formatting:** Good.
- **Clarity:** Clear distinction between groups.
- **Storytelling:** This is more of a "mechanism" check.
- **Recommendation:** **MOVE TO APPENDIX**

### Table 6: "Unwinding Cohorts"
**Page:** 26
- **Formatting:** Note: The PDF has two labels "Table 5" and "Table 6" for the same/overlapping info.
- **Clarity:** Good summary of the experiment.
- **Storytelling:** Helps with the "staggered adoption" context.
- **Recommendation:** **REVISE**
  - Fix the numbering (it skips from Table 5 to Table 6 in the same header).
  - Consolidate this with the summary statistics or move to the Data section as a small inline table.

### Table 7: "Robustness Checks"
**Page:** 26
- **Formatting:** Dense.
- **Clarity:** Mixing "BH vs CPT" (placebo group) and "Individual/Organization" (subsamples) in one row is a bit confusing.
- **Storytelling:** Demonstrates the "Pervasive Null."
- **Recommendation:** **REVISE**
  - Split into Panel A (Placebo Tests) and Panel B (Subsample Heterogeneity).

### Figure 8: "Randomization Inference: Permutation Distribution of DDD Coefficient"
**Page:** 28
- **Formatting:** Excellent. The red line for the observed coefficient is standard.
- **Clarity:** Immediate takeaway: the result is not an outlier.
- **Storytelling:** High value for a null-result paper to prove it's not a p-hacking artifact.
- **Recommendation:** **KEEP AS-IS**

---

## Appendix Exhibits

### Table 8: "Variable Definitions"
**Page:** 39
- **Recommendation:** **KEEP AS-IS** (Standard for T-MSIS papers).

### Table 9: "Alternative Inference for Main DDD Coefficient"
**Page:** 41
- **Recommendation:** **REMOVE**
  - This information is already conveyed in the main text through the RI p-value and Table 3. A single sentence in the text is sufficient.

### Figure 9 & 10: "Appendix Versions"
**Page:** 45-46
- **Recommendation:** **REMOVE**
  - These are just larger versions of main text figures. Unless the main text versions are unreadable (they aren't), these add no value.

---

## Overall Assessment

- **Exhibit count:** 5 Main Tables, 7 Main Figures, 1 Appendix Table, 2 Appendix Figures (excluding duplicates).
- **General quality:** Extremely high. The paper follows the "Modern DiD" visual style (event studies, dose-response scatters, RI distributions) preferred by the AEA journals.
- **Strongest exhibits:** Table 3 (The Comprehensive Null) and Figure 5 (State Variation).
- **Weakest exhibits:** Figure 4 (too noisy) and Table 7 (too much disparate info in one row).
- **Missing exhibits:** 
  1. **Map of Unwinding Intensity:** A US choropleth map showing disenrollment rates would be more impactful than the bar chart (Figure 5) for a "Top 5" journal.
  2. **Alternative Estimator Plot:** Since the paper mentions Callaway-Sant'Anna, even if the stagger is short, a plot showing that CS and TWFE yield the same null would preempt reviewer 2.

### Top 3 Improvements:
1.  **Consolidate Summary Statistics:** Merge Tables 1 and 2 into a single Table 1 with Panels A and B. This is the standard QJE/AER format.
2.  **Streamline the Main Text:** Move Figure 3 (Provider Counts), Figure 4 (Exit Rates), and Figure 7 (HHI) to the Appendix. This keeps the main text focused on the primary spending results and the "Resilience" story.
3.  **Enhance Robustness Table:** Restructure Table 7 into panels. Group the CPT placebo and the "Fake Post" into a "Validation" panel, and the Individual/Org splits into a "Heterogeneity" panel.